Haruko Tashiro

2.2k total citations · 1 hit paper
57 papers, 1.6k citations indexed

About

Haruko Tashiro is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Haruko Tashiro has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 20 papers in Hematology and 15 papers in Immunology. Recurrent topics in Haruko Tashiro's work include CAR-T cell therapy research (20 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Haruko Tashiro is often cited by papers focused on CAR-T cell therapy research (20 papers), Acute Myeloid Leukemia Research (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Haruko Tashiro collaborates with scholars based in Japan, United States and Germany. Haruko Tashiro's co-authors include Malcolm K. Brenner, Maksim Mamonkin, Rayne H. Rouce, Cliona M. Rooney, Bilal Omer, Hao Liu, Thomas Shum, Stephen Gottschalk, Gianpietro Dotti and Birju Mehta and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Haruko Tashiro

52 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

2017 391 citations Andras Heczey, Chrystal U. Louis et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haruko Tashiro Japan	13	1.3k	536	477	449	362	57	1.6k
Jonathan D. Fish United States	17	985 0.8×	476 0.9×	467 1.0×	362 0.8×	290 0.8×	32	1.6k
Monica Casucci Italy	16	1.6k 1.2×	654 1.2×	527 1.1×	466 1.0×	495 1.4×	35	1.9k
Barbara Camisa Italy	13	1.8k 1.4×	1.2k 2.2×	598 1.3×	533 1.2×	518 1.4×	27	2.6k
Sherry Adkins United States	9	1.9k 1.4×	503 0.9×	451 0.9×	472 1.1×	543 1.5×	14	2.1k
Dimitrios L. Wagner Germany	13	1.2k 0.9×	483 0.9×	904 1.9×	532 1.2×	311 0.9×	26	1.8k
Nicholas Tschernia United States	7	2.1k 1.6×	614 1.1×	590 1.2×	656 1.5×	558 1.5×	20	2.3k
Yongxian Hu China	21	1.1k 0.9×	353 0.7×	475 1.0×	324 0.7×	261 0.7×	119	1.4k
D. Stroncek United States	5	2.1k 1.6×	665 1.2×	580 1.2×	652 1.5×	556 1.5×	12	2.3k
Colette Chaney United States	13	1.3k 1.0×	733 1.4×	380 0.8×	432 1.0×	293 0.8×	19	1.7k

Countries citing papers authored by Haruko Tashiro

Since Specialization

Citations

This map shows the geographic impact of Haruko Tashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruko Tashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruko Tashiro more than expected).

Fields of papers citing papers by Haruko Tashiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruko Tashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruko Tashiro. The network helps show where Haruko Tashiro may publish in the future.

Co-authorship network of co-authors of Haruko Tashiro

This figure shows the co-authorship network connecting the top 25 collaborators of Haruko Tashiro. A scholar is included among the top collaborators of Haruko Tashiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruko Tashiro. Haruko Tashiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsumoto, Kensuke, et al.. (2025). Guillain-Barré syndrome with T-cell receptor gene clonal rearrangement following COVID-19 vaccination: a case report. Clinical and Experimental Vaccine Research. 14(3). 294–294.

Tashiro, Haruko. (2024). [CAR T-cell therapy for T cell malignancies: challenges and recent advances].. PubMed. 65(7). 644–651. 1 indexed citations

Tashiro, Haruko, Ryosuke Shirasaki, Tadashi Yamamoto, et al.. (2022). The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients. Leukemia Research. 113. 106790–106790. 2 indexed citations

Yanada, Masamitsu, Takahiro Fukuda, Kazutaka Ozeki, et al.. (2022). Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia. Transplantation and Cellular Therapy. 28(12). 847.e1–847.e8. 5 indexed citations

Hasegawa, Aiko, Shoji Saito, Shigeru Nakano, et al.. (2021). Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia. Clinical & Translational Immunology. 10(5). e1282–e1282. 21 indexed citations

Tashiro, Haruko, et al.. (2021). Second allogeneic transplantation using umbilical cord blood for a patient with relapsed ALK+ anaplastic large cell lymphoma after allogeneic bone marrow transplantation in the era of ALK inhibitors. Medicine. 100(15). e25576–e25576. 2 indexed citations

Kurosawa, Saiko, Hiroki Yamaguchi, Takuhiro Yamaguchi, et al.. (2020). The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse. International Journal of Hematology. 112(2). 200–209. 10 indexed citations

Omer, Bilal, Paul Castillo, Haruko Tashiro, et al.. (2018). Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells. Frontiers in Medicine. 5. 343–343. 15 indexed citations

Shum, Thomas, Bilal Omer, Haruko Tashiro, et al.. (2017). Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discovery. 7(11). 1238–1247. 220 indexed citations

10.

Tanaka, Miyuki, Haruko Tashiro, Bilal Omer, et al.. (2017). Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells. Clinical Cancer Research. 23(14). 3499–3509. 81 indexed citations

11.

Gomes‐Silva, Diogo, Haruko Tashiro, Madhuwanti Srinivasan, et al.. (2017). Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia. Blood. 130. 2642–2642. 2 indexed citations

12.

Tashiro, Haruko, et al.. (2017). Low High-Density Lipoprotein Cholesterol (HDL) Is a Significant Poor Prognostic Factor in Malignant Lymphoma. Blood. 130. 5148–5148. 2 indexed citations

13.

Tashiro, Haruko, Tim Sauer, Thomas Shum, et al.. (2017). Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Molecular Therapy. 25(9). 2202–2213. 116 indexed citations

14.

Heczey, Andras, Chrystal U. Louis, Barbara Savoldo, et al.. (2017). CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Molecular Therapy. 25(9). 2214–2224. 391 indexed citations breakdown →

15.

Tashiro, Haruko & Malcolm K. Brenner. (2016). Immunotherapy against cancer-related viruses. Cell Research. 27(1). 59–73. 103 indexed citations

16.

Tashiro, Haruko, Tadashi Yamamoto, Nobu Akiyama, et al.. (2014). Hyperuricemia in Hematologic Malignancies Is Caused by an Insufficient Urinary Excretion. Nucleosides Nucleotides & Nucleic Acids. 33(4-6). 434–438. 11 indexed citations

17.

Shirasaki, Ryosuke, Haruko Tashiro, Tadashi Yamamoto, et al.. (2011). Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19). International Journal of Hematology. 94(2). 203–208. 3 indexed citations

18.

Hanawa, Naoko, Atsushi Tanaka, Ryo Miura, et al.. (2010). Autoimmune neutropenia due to antineutrophil antibodies in a patient with primary sclerosing cholangitis. Clinical Journal of Gastroenterology. 3(3). 149–154. 1 indexed citations

19.

Tashiro, Haruko, Ryosuke Shirasaki, Toshiyuki Miura, et al.. (2009). Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART. International Journal of Hematology. 91(1). 140–145. 3 indexed citations

20.

Tashiro, Haruko, et al.. (2009). Acute myelogenous leukemia cells with the MLL–ELL translocation convert morphologically and functionally into adherent myofibroblasts. Biochemical and Biophysical Research Communications. 391(1). 592–597. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact